Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Mochida Pharmaceutical Co., Ltd. ( (JP:4534) ) just unveiled an announcement.
Mochida Pharmaceutical Co., Ltd. announced its consolidated financial results for the nine months ending December 31, 2024, showing a significant improvement in operating and ordinary profit compared to the previous year. The company reported a 3.2% increase in net sales and marked a substantial rise in profits, indicating a strong performance in its operations despite a drop in comprehensive income.
More about Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily engaged in the pharmaceutical industry. The company focuses on the development, production, and sale of pharmaceutical products.
YTD Price Performance: -3.81%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €730.9M
Learn more about 4534 stock on TipRanks’ Stock Analysis page.
